Symposium speakers 2015: Ahmet Hoke

Neuro X is the title and theme for the May 1 symposium hosted by Johns Hopkins Institute for NanoBioTechnology. The event kicks off with a continental breakfast at 8 a.m. in the Owens Auditorium, between CRB I and CRB II on the Johns Hopkins University medical campus. Talks begin at 9 a.m. Posters featuring multidisciplinary research from across many Hopkins divisions and departments will be on display from 1 p.m. to 4 p.m.

One of this year’s speakers is Ahmet Hoke MD, PhD.

Ahmet Hoke, MD, PhD

Ahme Hoke, MD, PhD

Dr. Ahmet Hoke received his medical degree from Hacettepe University in Ankara, Turkey. He then completed an internship and residency in medicine at MetroHealth Saint Luke’s Medical Center in Cleveland, OH. He completed his Ph.D. in Neuroscience at Case Western Reserve University before joining Johns Hopkins for his neurology residency. He went on to the University of Calgary for a neuromuscular fellowship. Dr. Hoke is currently a professor of Neurology and Neuroscience and the director of the Daniel B. Drachman Division of Neuromuscular Diseases at Johns Hopkins School of Medicine, where he focuses on neuromuscular diseases with a particular interest in peripheral nerve diseases. He has specialized expertise in nerve conduction studies, electromyography and nerve and muscle biopsy reading. In 2005, he received the coveted Derek Denny Brown Young Neurological Scholar Award given by the American Neurological Association to a member of the association who has achieved significant stature in neurological research and whose promise of continuing major contributions to the field of neurology is anticipated.

Dr. Hoke’s research interests includes studies on biology of peripheral axons and Schwann cells and disorders affecting the peripheral nervous system. He uses in vitro and in vivo models of peripheral neuropathies (HIV-associated sensory neuropathy, diabetic neuropathy and toxic neuropathies) to study the mechanism of axonal damage and develop therapeutic targets for drug development. In addition, he has an additional research interest focusing on mechanisms of axonal degeneration and regeneration using in vitro and in vivo models. He researches novel chemicals to treat peripheral neuropathies and utilizes engineered stem cells as therapeutic gene delivery tools to promote axonal regeneration in chronically denervated nerves as seen in nerve injuries and many degenerating disorders of the peripheral nervous system such as amyotrophic lateral sclerosis and inherited neuropathies.

Additional speakers will be profiled in the next few weeks. To register your poster and for more details visit http://inbt.jhu.edu/news/symposium/

For all press inquiries regarding INBT, its faculty and programs, contact Mary Spiro, mspiro@jhu.edu or 410-516-4802.

Leave a Comment

*